AzTrials
AzTrials

Voice DisordersNCT01196611

Effectiveness of Two Therapeutic Approaches in Female Teachers With Voice Disorders

A study testing Voice Amplification and Function Voice Exercises in people with Voice Disorders, run by Federal University of São Paulo at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study compares two different approaches of voice therapy. Vocal Functional Exercises (Stemple,1997) and Voice Amplification using a portable amplifier (Tsi Supervoz II - Tecnisystem do Brasil TSI 1210). Read more about this study

Who is it for?
Ages 21 to 50 years, women only
Conditions the study is for
Voice Disorders
What is being tested?
Voice Amplification and Function Voice Exercises
Could I receive a placebo?
No, everyone receives an active treatment
How many people
162 participants
Where
1 siteBrazil
Study dates
Sep 2010to Mar 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 50 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Female teacher
  • 21-50 years old.
  • Full or part time elementary to middle school teacher ( Prefeitura Municipal de Belo Horizonte).
  • Minimum 20 hour weekly workload.
  • Medical reference to speech therapy due to behavioral dysphonia

Who cannot join

  • Physical education or daycare teachers.
  • Professional singers.
  • Neurological and/or psychiatric voice disorders

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Universidade Federal de Sao Paulo

    São Paulo, São Paulo

Other trials in Brazil

About this study

The study compares two different approaches of voice therapy. Vocal Functional Exercises (Stemple,1997) and Voice Amplification using a portable amplifier (Tsi Supervoz II - Tecnisystem do Brasil TSI 1210).

Read the detailed description

Both approaches combined with Vocal Hygiene Program (Behlau, 2007).The target population are female teachers because they have the highest risk for developing voice problems. For this study the investigators are primarily interested in seeing if Vocal Functional Exercises and Voice Amplification are equally effective at improving vocal functioning in teachers with voice disorders. The Fiberoptic endoscopic evaluation will be done before randomization. All the participants will complete before and after a 6-week treatment phase (a) Voice Activity and Participation Profile (PPAV), an instrument designed to appraise the self-perceived psychosocial consequences of voice disorders to assess the impact of voice disorders on daily activities (b) Audio voice recording for later acoustic analysis, through the Kay Elemetrics Multi Dimensional Voice Program (c) Audio recording for later perceptual analysis through Consensus Auditory-Perceptual Evaluation of Voice (CAPE_V). It is believed that the search for evidence in clinical studies like this can contribute to awareness programs and vocal training for teachers.

Conditions
Voice Disorders
Being tested
Voice Amplification, Function Voice Exercises
Keywords
Voice disorders, Voice
Medical subject headings
Voice Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Voice AmplificationBehavioural

    Behavioral: Voice Amplification. Patients use VA over a course of 6 weeks Control group. No treatment over a course of 6 weeks.

  • Function Voice ExercisesBehavioural

    Function Voice Exercises Patients will receive 6 sessions of therapy over a course of 6 weeks, with one session per week.

Study groups in NCT01196611
Study groupRoleWhat they receive
Function Voice ExercisesExperimentalBehavioral: Function Voice Exercises Patients will receive 6 sessions of therapy over a course of 6 weeks, with one session per week.
Receives: Behavioral: Function Voice Exercises
Voice amplificationExperimentalBehavioral: Voice amplification Patients will use VA over a course of 6 weeks.
Receives: Behavioral: Voice Amplification

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fiberoptic endoscopic evaluation

    Measured: One year

  2. Score(CAPE_V); score(PPAV); score on acoustic analysis

    Measured: One year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2010 (estimated)
  2. Study startSep 2010
  3. Primary completionSep 2012
  4. Study completionMar 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
162 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01196611
Sponsor's protocol ID
ETIC 0521.0.203.000-09
Status last verified
Sep 2010
First submitted
3 Sep 2010
Last updated
30 Mar 2017
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No: The data of the participants are confidential

Questions about this trial

What is this clinical trial studying?

A study testing Voice Amplification and Function Voice Exercises in people with Voice Disorders, run by Federal University of São Paulo at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Mar 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fiberoptic endoscopic evaluation (time frame: One year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in